Cite

HARVARD Citation

    Verberne, C. et al. (2016). Cost‐effectiveness of a carcinoembryonic antigen (CEA) based follow‐up programme for colorectal cancer (the CEA Watch trial). Colorectal disease. pp. O91-O96. [Online]. 
  
Back to record